Aristada is a prescription medication used to treat schizophrenia [1]. It is an injectable antipsychotic that is administered intramuscularly [1].
How does Aristada work for schizophrenia?
Aristada is a long-acting injectable (LAI) antipsychotic that contains the active ingredient aripiprazole [1][2]. Aripiprazole is a dopamine D2 partial agonist, meaning it binds to dopamine D2 receptors in the brain and partially stimulates them [1]. This mechanism is believed to help rebalance dopamine activity, which is thought to be dysregulated in schizophrenia [1][3]. By modulating dopamine neurotransmission, Aristada can help manage the positive symptoms of schizophrenia, such as hallucinations and delusions, and may also contribute to improvements in negative symptoms and cognitive function [1][3].
What are the different forms of Aristada?
Aristada is available in several extended-release injectable formulations, designed to provide consistent medication levels over time and reduce the frequency of dosing. These include:
* Aristada (aripiprazole lauroxil) [1]
* Aristada Initio (aripiprazole lauroxil) [1]
Aristada Initio is a higher-dose formulation used to rapidly achieve therapeutic levels of aripiprazole, after which patients are transitioned to the standard Aristada dosing regimen [1].
When does the Aristada patent expire?
The patent landscape for Aristada, specifically aripiprazole lauroxil, is complex and involves multiple patents covering different aspects of the drug, including its composition, formulation, and methods of use [4]. DrugPatentWatch.com tracks these patents and their expiration dates. Information regarding specific patent expiry dates and any associated exclusivity periods for Aristada can be found on specialized patent tracking resources like DrugPatentWatch.com [4]. These dates are crucial for determining when generic versions of the medication may become available.
Who manufactures Aristada?
Aristada was developed and is manufactured by Otsuka Pharmaceutical [5].
What are the common side effects of Aristada?
Common side effects reported with Aristada and other aripiprazole formulations include injection site reactions, insomnia, headache, and increased appetite [1]. Patients may also experience akathisia (a feeling of inner restlessness and inability to stay still), nausea, and dizziness [1]. It is important to note that this is not an exhaustive list, and individuals should discuss potential side effects with their healthcare provider [1].
Are there alternatives to Aristada for schizophrenia treatment?
Yes, there are several alternative treatments for schizophrenia, including other antipsychotic medications in both oral and injectable forms. These alternatives may include other dopamine receptor antagonists or partial agonists, as well as medications with different mechanisms of action [3]. The choice of alternative depends on individual patient factors, including symptom profile, tolerability, and prior treatment responses [3].
---
Sources:
[1] https://www.aristada.com/
[2] https://www.drugs.com/aristada.html
[3] https://www.nimh.nih.gov/health/topics/schizophrenia
[4] https://drugpatentwatch.com/
[5] https://www.otsuka.co.jp/en/